$ABCL Cashflow Statement | Understand Stock

$ABCL

$12.63 +$0.55 (4.55%) Live

$ABCL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment
Amortization of intangible assets
Amortization and impairment of intangible assets
Amortization of operating lease right-of-use assets
Stock-based compensation
Deferred tax (expense) recovery
Fair value (gain) loss on contingent consideration and investments
Other
Changes in operating assets and liabilities:
Research fees and grants receivable
Accrued royalties receivable
Income taxes (payable) receivable
Operating lease liabilities
Accounts payable and other liabilities
Accounts payable and accrued liabilities
Deferred revenue
Accrued royalties payable
Deferred grant income
Other operating assets and liabilities
Other assets

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchase of intangible assets
Purchase of marketable securities
Proceeds from marketable securities
Receipt of grant funding
Acquisitions
Distribution from equity accounted investees
Investment in and loans to equity accounted investees
Proceeds from repayment of loan from joint venture partner
Long-term investments and other assets
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Repayment of long-term debt
Proceeds from long-term debt
Repayment of long-term debt and contingent consideration
Payment of contingent consideration
Payment of liability for in-licensing agreement
Issuance of common shares pursuant to exercise of stock options and other
Payment of liability for in-licensing agreement, contingent consideration, and other
Payment of liability for in-licensing agreement and other
Proceeds from long-term liabilities and other
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents and restricted cash, beginning of period
Cash and cash equivalents and restricted cash, end of period
Restricted cash included within other current and other long-term assets
Restricted cash included in other assets
Total cash, cash equivalents, and restricted cash shown on the balance sheet
Supplemental disclosure of non-cash investing and financing activities
Property and equipment in accounts payable
Right-of-use assets obtained in exchange for operating lease obligation

Comments